Andrx naproxen ER approved
Andrx' 500 mg naproxen extended-release ANDA clears FDA Aug. 27. SkyePharma waived its 180-day exclusivity for generic Naprelan after Andrx brought suit against SkyePharma and Elan, claiming they had entered a non-public anticompetitive settlement related to the product (1"The Pink Sheet" April 9, 2001, p. 4). Andrx expects to launch the generic in September. Company also has 375 mg strength tentatively approved at FDA...
You may also be interested in...
Aventis and Andrx' consent agreement with the Federal Trade Commission includes an acknowledgement by the agency that the patent litigation settlement between the two companies did not delay the advent of generic competition to Cardizem CD.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.